About the Authors

Yukari C. Manabe

ymanabe@jhmi.edu

Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

Sabine M. Hermans

Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

Mohammed Lamorde

Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland

Barbara Castelnuovo

Affiliation Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda

C. Daniel Mullins

Affiliation University of Maryland, Baltimore, Maryland, United States of America

Andreas Kuznik

Affiliation Pfizer Inc., New York, New York, United States of America

Competing Interests

AK is an employee of Pfizer, Inc. and did this work while at IDI as a Pfizer Global Fellow. Dr. Mullins has received consultant’s fees from Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb Company, Eisai Ltd, Novartis, Pfizer, and Sanofi-Aventis; and grant support from Bayer, Novartis, Pfizer, and Sanofi-Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: YCM SMH ML BC CDM AK. Performed the experiments: SMH ML AK. Analyzed the data: YCM SMH ML BC CDM AK. Wrote the paper: YCM SMH ML BC CDM AK.